Furthermore, Miki et al. and Lewitowicsz et al. also reported the positive correlation of CD63 higher expression with the poor survival rate of gastric and gastrointestinal stromal tumor [39,40]. This evidence concerns the gene CD63 and gastrointestinal stromal tumor.